The share price is irrelevant at the moment, if everything progresses as planned with phase2/3 (Cohart 4 10mg/kg study), we'll possibly see the SP around $2.0 at this time of July 2025 (some time things happens much faster similar to DXB). It is too early to claim anything before next read out, however if FDA approval announced by early 2026, the sky is the limit. The PAA holding goes at the bottom of the shelve but will be watching post in HC to understand investor sentiments.
The share price is irrelevant at the moment, if everything...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $145.3K | 876.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38307 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 302337 | 3 |
View Market Depth
| Last trade - 15.51pm 23/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |